Rui Yu

46 papers receiving 1.1k citations

Hit Papers

Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling 2021 · 192 citations
192202120262022202450100150

Peers

Rui Yu
Comparison fields: 5 of 120
  • Biological Psychiatry 32
  • Geriatrics and Gerontology 44
  • Cancer Research 158
  • Hepatology 78
  • Dermatology 86
Replace Vojtěch Mezera with:
Vojtěch Mezera Czechia
Yukari Zenke Japan
Jamshid Karimi Iran
Huiping Yuan China
Weijun Huang China
Yehuda Kamari Israel
Honglan Zhou China
Rui Yu relative to Vojtěch Mezera Czechia Vojtěch Mezera's profile →
Citations per field
00.5×3.4×
Vojtěch Mezera · 1×
Citations per year

Countries citing papers authored by Rui Yu

Since Specialization
Citations

This map shows the geographic impact of Rui Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Yu more than expected).

Fields of papers citing papers by Rui Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Yu. The network helps show where Rui Yu may publish in the future.

Co-authors

The 25 scholars most cited alongside Rui Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rui Yu Line = papers co-authored together Rui Yu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20250
3 20250
4 20251
5 20250
6 20250
7 20243
8 20241
9 20244
10 20244
11 20215
12 202111
13 201865
14 201711
15 2017121
16 201447
17 201320
18 201131
19 19975
20 1991106

About Rui Yu

Rui Yu is a scholar working on Nephrology, Biological Psychiatry, Geriatrics and Gerontology, Hepatology and Pathology and Forensic Medicine, having authored 52 papers that have together received 1.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Inflammatory mediators and NSAID effects (5 papers), Hepatitis B Virus Studies (4 papers), Diabetes Treatment and Management (4 papers), Dialysis and Renal Disease Management (4 papers), Estrogen and related hormone effects (3 papers), Diet and metabolism studies (3 papers) and Schizophrenia research and treatment (3 papers). The work is most often cited by research in Biological Psychiatry (32 citations), Geriatrics and Gerontology (44 citations), Cancer Research (158 citations), Hepatology (78 citations) and Dermatology (86 citations). Rui Yu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Chunxiao Wang, Lei Yu, Dazhi Fu, D.W. PRYCE, A.W. MACFARLANE, Richard B. van Breemen, Yanqiu Wang, Rong Fan, Jinlin Hou and Beiru Zhang. Their work appears in journals such as Clinical and Experimental Pharmacology and Physiology, PLoS ONE, Journal of Craniofacial Surgery, International Journal of Environmental Science and Technology and Frontiers in Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026